ANNA MARIA BIAVA

Dr. ANNA MARIA BIAVA

Sapienza Univeristy of Rome Department of Medico-Surgical Sciences and Biotechnologies
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NTNardi Tetaj
Nardi Tetaj
Gennaro De PascaleGennaro De Pascale
Gennaro De Pascale
MAMassimo Antonelli
Massimo Antonelli
JVJoel Vargas
Joel Vargas
MSMartina Savino
Martina Savino
ENEmanuele Nicastri
Emanuele Nicastri
Introduction: Coronavirus disease 2019 (COVID-19) is a significant and novel cause of acute respiratory distress syndrome (ARDS). During the COVID-19 pandemic, there has been an increase in the incidence of cases involving pneumothorax and pneumomediastinum. However, the risk factors associated with poor outcomes in these patients remain unclear. Methods: This observational study collected clinical and imaging data from COVID-19 patients with PTX and/or PNM across five tertiary hospitals in central Italy between 1 March 2020 and 1 March 2022. This study also calculated the incidence of PTX and PNM and utilized multivariable regression analysis and Kaplan–Meier curve analysis to identify predictor factors for 28-day mortality and 3-day orotracheal intubation after PTX/PNM. This study also considered the impact of the three main variants of concern (VoCs) (alfa, delta, and omicron) circulating during the study period. Results: During the study period, a total of 11,938 patients with COVID-19 were admitted. This study found several factors independently associated with a higher risk of death in COVID-19 patients within 28 days of pulmonary barotrauma. These factors included a SOFA score ≥ 4 (OR 3.22, p = 0.013), vasopressor/inotropic therapy (OR 11.8, p < 0.001), hypercapnia (OR 2.72, p = 0.021), PaO2/FiO2 ratio < 150 mmHg (OR 10.9, p < 0.001), and cardiovascular diseases (OR 7.9, p < 0.001). This study also found that a SOFA score ≥ 4 (OR 3.10, p = 0.015), PCO2 > 45 mmHg (OR 6.0, p = 0.003), and P/F ratio < 150 mmHg (OR 2.9, p < 0.042) were factors independently associated with a higher risk of orotracheal intubation (OTI) within 3 days from PTX/PNM in patients with non-invasive mechanical ventilation. SARS-CoV-2 VoCs were not associated with 28-day mortality or the risk of OTI. The estimated cumulative probability of OTI in patients after pneumothorax was 44.0% on the first day, 67.8% on the second day, and 68.9% on the third day, according to univariable survival analysis. In patients who had pneumomediastinum only, the estimated cumulative probability of OTI was 37.5%, 46.7%, and 57.7% on the first, second, and third days, respectively. The overall incidence of PTX/PNM among hospitalized COVID-19 patients was 1.42%, which increased up to 4.1% in patients receiving invasive mechanical ventilation. Conclusions: This study suggests that a high SOFA score (≥4), the need for vasopressor/inotropic therapy, hypercapnia, and PaO2/FiO2 ratio < 150 mmHg in COVID-19 patients with pulmonary barotrauma are associated with higher rates of intubation, ICU admission, and mortality. Identifying these risk factors early on can help healthcare providers anticipate and manage these patients more effectively and provide timely interventions with appropriate intensive care, ultimately improving their outcomes.

17 December 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
LMLuigi Maggi
Luigi Maggi
ABANNA MARIA BIAVA
ANNA MARIA BIAVA
SFSilvia Fiorelli
Silvia Fiorelli
Flaminia ColuzziFlaminia Coluzzi
Flaminia Coluzzi
Alberto RicciAlberto Ricci
Alberto Ricci
Monica RoccoMonica Rocco
Monica Rocco
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide causing a global pandemic. In this context, lung ultrasound (LUS) has played an important role due to its high diagnostic sensitivity, low costs, simplicity of execution and radiation safeness. Despite computed tomography (CT) being the imaging gold standard, lung ultrasound point of care exam is essential in every situation where CT is not readily available nor applicable. The aim of our review is to highlight the considerable versatility of LUS in diagnosis, framing the therapeutic route and follow-up for SARS-CoV-2 interstitial syndrome.

1 April 2023 in Journal of Anesthesia
Verified
Journal Article
Closed access
PDF file
ABANNA MARIA BIAVA
ANNA MARIA BIAVA
GCGianni Cipriani
Gianni Cipriani
FBFederico Bilotta
Federico Bilotta

14 August 2024 in Journal of Anesthesia
Verified
Journal Article
Closed access
PDF file
ABANNA MARIA BIAVA
ANNA MARIA BIAVA
GCGianni Cipriani
Gianni Cipriani
EMEndrit Malja
Endrit Malja
FBFederico Bilotta
Federico Bilotta

17 August 2023 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
ABANNA MARIA BIAVA
ANNA MARIA BIAVA
GCGianni Cipriani
Gianni Cipriani
FBFederico Bilotta
Federico Bilotta

31 October 2023 in Journal of Anesthesia
Verified
Journal Article
Closed access
PDF file
ABANNA MARIA BIAVA
ANNA MARIA BIAVA
GCGianni Cipriani
Gianni Cipriani
EMEndrit Malja
Endrit Malja
FBFederico Bilotta
Federico Bilotta